Biosimilars Company Strategies to Capture Value from the Biologics Market.docVIP

Pharmaceuticals2012,5,1393-1408;doi:10.3390/ph5121393 OPENACCESS pharmaceuticals ISSN1424-8247 /journal/pharmaceuticals Article Biosimilars:CompanyStrategiestoCaptureValuefromthe BiologicsMarket BrunoCalo-Fern′andez 1,*andJuanLeonardoMart′?nez-Hurtado 2, * 1 2 EscuelaT′ecnicaSuperiordeIngenier′?a,UniversidaddeSantiagodeCompostela,R′uaLopeG′omezde Marzoas/n,CampusVida15782,SantiagodeCompostela,Spain InstituteofBiotechnology,UniversityofCambridge,TennisCourtRd,CB41QT,Cambridge,UK *Authorstowhomcorrespondenceshouldbeaddressed;E-Mails:bruno.calo@rai.usc.es(B.C-F.); j.leonardo@biotech.cam.ac.uk